Cancer Medicine (Apr 2024)

Survival trends for left and right sided colon cancer using population‐based SEER database: A forty‐five‐year analysis from 1975 to 2019

  • Mark B. Ulanja,
  • Kwabena Oppong Asafo‐Agyei,
  • Vijay Neelam,
  • Bryce D. Beutler,
  • Daniel Antwi‐Amoabeng,
  • Samuel B. Governor,
  • Ganiyu A. Rahman,
  • Francis T. Djankpa,
  • Reginald N. Ulanja,
  • Grace B. Nteim,
  • Tarig Mabrouk,
  • Millicent Amankwah,
  • Olatunji B. Alese

DOI
https://doi.org/10.1002/cam4.7145
Journal volume & issue
Vol. 13, no. 8
pp. n/a – n/a

Abstract

Read online

Abstract Background Survival differences between left‐sided colon cancer (LSCC) and right‐sided colon cancer (RSCC) has been previously reported with mixed results, with various study periods not accounting for other causes of mortality. Purpose We sought to assess the trends in colon cancer cause‐ specific survival (CSS) and overall survival (OS) based on sidedness. Method Fine‐Gray competing risk and Cox models were used to analyze Surveillance, Epidemiology, and End Results (SEER) population‐based cohort from 1975 to 2019. Various interval periods were identified based on the timeline of clinical adoption of modern chemotherapy (1975–1989, interval period A; 1990–2004, B; and 2005–2019, C). Results Of the 227,637 patients, 50.1% were female and 46.2% were RSCC. RSCC was more common for African Americans (51.5%), older patients (age ≥65; 51.4%), females (50.4%), while LSCC was more common among Whites (53.1%; p < 0.001), younger patients (age 18–49, 64.6%; 50–64, 62.3%; p < 0.001), males (58.1%; p < 0.001). The Median CSS for LSCC and RCC were 19.3 and 16.7 years respectively for interval period A (1975–1989). Median CSS for interval periods B and C were not reached (more than half of the cohort was still living at the end of the follow‐up period). Adjusted CSS was superior for LSCC versus RSCC for the most recent interval period C (HR 0.89; 0.86–0.92; p < 0.001). LSCC consistently showed superior OS for all study periods. Stage stratification showed worse CSS for localized and regional LSCC in the earlier study periods, but the risk attenuated over time. However, left sided distant disease had superior CSS per stage for all interval periods. OS was better for LSCC irrespective of stage, with gradual improvement over time. Conclusion LSCC was associated with superior survival compared to right sided tumors. With the adoption of modern chemotherapy regimens, prognosis between LSCC and RSCC became more divergent in favor of LSCC. Colon cancer clinical trials should strongly consider tumor sidedness as an enrollment factor.

Keywords